Author:
Wu Lihteh,Martínez-Castellanos María A.,Quiroz-Mercado Hugo,Arevalo J. Fernando,Berrocal María H.,Farah Michel E.,Maia Mauricio,Roca José A.,Rodriguez Francisco J.,
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference33 articles.
1. Adamis AP, Aiello LP, D’Amato RA (1999) Angiogenesis and ophthalmic disease. Angiogenesis 3:9–14
2. Adamis AP, Shima DT (2005) The role of vascular endothelial growth factor in ocular health and disease. Retina 25:111–118
3. Qaum T, Xu Q, Joussen AM, et al (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408–2413
4. Saishin Y, Saishin Y, Takahashi K, et al (2003) VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:241–248
5. Cunningham ET Jr, Adamis AP, Altaweel M, et al (2005) A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747–1757
Cited by
395 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献